Published December 2019 | Version v1
Journal article

Silencing TTK expression inhibits the proliferation and progression of prostate cancer

  • 1. Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211 (China)
  • 2. Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, V5Z 1L3 (Canada)
  • 3. Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, V6H 3Z6 (Canada)

Description

The main objective of our study was to explore changes in the expression levels of differentially expressed genes associated with prostate cancer progression and to design a series of experiments to verify the function of differentially expressed genes.

Additional details

Identifiers

DOI
10.1016/j.yexcr.2019.111669;
PII
S0014482719305403;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
385
Journal Issue
1
Journal Page Range
vp.
ISSN
0014-4827
CODEN
ECREAL

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
55044453
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CELL CYCLE; CELL PROLIFERATION; GENES; NEOPLASMS; PROSTATE
Descriptors DEC
BODY; DISEASES; GLANDS; MALE GENITALS; ORGANS

Optional Information

Copyright
Copyright (c) 2019 Elsevier Inc. All rights reserved.